Clinical Trial Update: Safety, Pharmacokinetics and Pharmacodynamics of Two IDegAsp (One Explorative) Preparations and Two Insulin Degludec (One Explorative) Preparations in Japanese Subjects [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety, pharmacokinetics and pharmacodynamics of two IDegAsp preparations (one exploratory) and two insulin degludec preparations (one …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• IDegAsp (insulin degludec/insulin aspart)
• IDegAsp (Explorative 1) (insulin degludec/aspart)
• Insulin degludec (Explorative 1) (insulin degludec)
• insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Healthy | Phase 1 | Status: COMPLETED